Nuheara Announces Distribution of HP Hearing Pro Through Fuel Medical - Yahoo Finance

GRCLDelisted Stock  USD 4.02  0.26  6.07%   
About 62% of Gracell Biotechnologies' investor base is looking to short. The analysis of current outlook of investing in Gracell Biotechnologies suggests that many traders are alarmed regarding Gracell Biotechnologies' prospects. Gracell Biotechnologies' investing sentiment shows overall attitude of investors towards Gracell Biotechnologies.
  
Nuheara Announces Distribution of HP Hearing Pro Through Fuel Medical Yahoo Finance

Read at news.google.com
Google News at Macroaxis
  

Gracell Biotechnologies Fundamental Analysis

We analyze Gracell Biotechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gracell Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gracell Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Market Capitalization

Market Capitalization Comparative Analysis

Gracell Biotechnologies is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Gracell Biotechnologies Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gracell Biotechnologies stock to make a market-neutral strategy. Peer analysis of Gracell Biotechnologies could also be used in its relative valuation, which is a method of valuing Gracell Biotechnologies by comparing valuation metrics with similar companies.

Peers

Gracell Biotechnologies Related Equities

GLUEMonte Rosa   13.72   
0%
100.0%
XFORX4 Pharmaceuticals   11.43   
0%
83.0%
CTMXCytomX Therapeutics   3.92   
0%
28.0%
BOLTBolt Biotherapeutics   1.59   
0%
11.0%
DAWNDay One   1.53   
0%
11.0%
BPMCBlueprint Medicines   1.35   
0%
9.0%
ASMBAssembly Biosciences   1.25   
0%
9.0%
SPROSpero Therapeutics   0.88   
0%
6.0%
DSGNDesign Therapeutics   0.50   
0%
3.0%
ABOSAcumen Pharmaceuticals   0.44   
0%
3.0%
INZYInozyme Pharma   0.37   
2.0%
0%
TERNTerns Pharmaceuticals   1.58   
11.0%
0%
ERASErasca   2.05   
14.0%
0%
NXTCNextCure   2.50   
18.0%
0%
CHRSCoherus BioSciences   3.17   
23.0%
0%
AMLXAmylyx Pharmaceuticals   3.48   
25.0%
0%
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Consideration for investing in Gracell Stock

If you are still planning to invest in Gracell Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gracell Biotechnologies' history and understand the potential risks before investing.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bonds Directory
Find actively traded corporate debentures issued by US companies